Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name POLYPID LTD Proposed Ticker POLY CUSIP M8001Q100 Business Description A clinical-stage pharmaceutical company focused on developing and commercializing novel, locally administered therapies using our transformational PLEX (Polymer-Lipid Encapsulation matriX) technology Lead Underwriter Cowen and Company, LLC ,Goldman Sachs & Co. LLC Co-Managers Cantor Fitzgerald & Co. ,Oppenheimer & Co. Inc. ,Raymond James and Associates, Inc. Initial Shares 33,33,333 Revised Initial Shares N/A Initial Price $21.00-$24.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.